12:00 AM
 | 
Apr 26, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Pomalidomide regulatory update

The COMP issued a positive opinion in favor of granting Orphan Drug designation for Celgene's pomalidomide to...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >